Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial elongation factor TUFM is a nuclear-encoded protein essential for mitochondrial protein synthesis. It facilitates the GTP-dependent binding of aminoacyl-tRNA to the ribosome A-site. Beyond translation, TUFM regulates programmed cell death pathways and is implicated in viral infection response and cancer. It is considered a potential therapeutic target due to its diverse roles.
Inhibiting TUFM's GTPase activity or tRNA binding to disrupt mitochondrial translation and/or affect cell death pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial elongation factor TUFM (TUFM).